ArticlePharmaceuticals (Basel, Switzerland)2023

HSPB5 Inhibition by NCI-41356 Reduces Experimental Lung Fibrosis by Blocking TGF-β1 Signaling.

Julie Tanguy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.